AngioDynamics, headquartered in Latham, New York, develops and sells medical devices for vascular access, oncology, and peripheral vascular disease, focusing on minimally invasive procedures. The company went public on May 27, 2004.
Angiodynamic (ANGO) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Angiodynamic's actual EPS was -$0.11, beating the estimate of -$0.15 per share, resulting in a 26.47% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
